Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

R Pazdur; J J Ajani; J L Abbruzzese; R J Belt; S R Dakhil; D Dubovsky; S Graham; S Pilat; R Winn; B Levin

doi:10.1002/1097-0142(19921015)70:8<2073::aid-cncr2820700810>3.0.co;2-a

Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

Identifier:nobleid.org/w1/20260515/95BFCEAD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/95BFCEAD.svg?ark=w1%2F20260515%2F95BFCEAD)](https://nobleid.org/work/w1/20260515/95BFCEAD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

Identifier:nobleid.org/w1/20260515/95BFCEAD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/95BFCEAD.svg?ark=w1%2F20260515%2F95BFCEAD)](https://nobleid.org/work/w1/20260515/95BFCEAD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work